Clinical Trial: Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Oral Topical Cyclooxygenase Inhibitor (Aspirin) Mouthwash for Treatment of Oral Dysplasia

Brief Summary:

RATIONALE: Aspirin mouthwash may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

PURPOSE: This phase I trial is studying the side effects and best dose of aspirin mouthwash in treating patients with oral leukoplakia.